share_log

S-3/A: Registration statement for specified transactions by certain issuers (Amendment)

S-3/A: Registration statement for specified transactions by certain issuers (Amendment)

S-3/A：特定交易注册声明(修正)
美股SEC公告 ·  08/16 16:35
Moomoo AI 已提取核心信息
SeaStar Medical Holding Corporation (SeaStar Medical) has filed an amendment to Form S-3 with the Securities and Exchange Commission (SEC) on August 16, 2024. The amendment pertains to the registration statement under the Securities Act of 1933 for the offering of up to 1,014,219 shares of common stock by selling securityholders. These shares are related to the exercise of certain warrants issued by SeaStar Medical. The company will not receive proceeds from the sale of shares by the selling securityholders but will receive the exercise price of the warrants unless exercised on a cashless basis. The selling securityholders may sell the shares through various methods including on exchanges, in the over-the-counter market, or through private transactions. The company has agreed to bear the costs associated with the registration of the shares, which are estimated to be $45,750. The registration allows the selling securityholders to sell their shares from time to time after the date of the prospectus, and the offering will be subject to various conditions including SEC rules and regulations.
SeaStar Medical Holding Corporation (SeaStar Medical) has filed an amendment to Form S-3 with the Securities and Exchange Commission (SEC) on August 16, 2024. The amendment pertains to the registration statement under the Securities Act of 1933 for the offering of up to 1,014,219 shares of common stock by selling securityholders. These shares are related to the exercise of certain warrants issued by SeaStar Medical. The company will not receive proceeds from the sale of shares by the selling securityholders but will receive the exercise price of the warrants unless exercised on a cashless basis. The selling securityholders may sell the shares through various methods including on exchanges, in the over-the-counter market, or through private transactions. The company has agreed to bear the costs associated with the registration of the shares, which are estimated to be $45,750. The registration allows the selling securityholders to sell their shares from time to time after the date of the prospectus, and the offering will be subject to various conditions including SEC rules and regulations.
SeaStar Medical Holding Corp.（SeaStar 医疗）于2024年8月16日向证券交易委员会（SEC）提交了S-3表格的修改申请。该修改申请涉及到根据《1933年证券法》注册声明的，售出安全持有人高达1,014,219股普通股的发行。这些股票与 SeaStar Medical发行的某些权证有关。公司将不会从安全持有人出售股票中收到任何收益，但除非通过无现金基础进行行使，否则公司将收到权证行使价。安全持有人可以通过各种方式进行股票销售，包括通过交易所、场外市场或私人交易。公司已同意承担与股票注册相关的成本，估计为45,750美元。注册使安全持有人得以在招股书日期后的任何时间以各种条件销售其股票，该发行将受到包括SEC规则和法规在内的各种条件限制。
SeaStar Medical Holding Corp.（SeaStar 医疗）于2024年8月16日向证券交易委员会（SEC）提交了S-3表格的修改申请。该修改申请涉及到根据《1933年证券法》注册声明的，售出安全持有人高达1,014,219股普通股的发行。这些股票与 SeaStar Medical发行的某些权证有关。公司将不会从安全持有人出售股票中收到任何收益，但除非通过无现金基础进行行使，否则公司将收到权证行使价。安全持有人可以通过各种方式进行股票销售，包括通过交易所、场外市场或私人交易。公司已同意承担与股票注册相关的成本，估计为45,750美元。注册使安全持有人得以在招股书日期后的任何时间以各种条件销售其股票，该发行将受到包括SEC规则和法规在内的各种条件限制。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息